May 11, 2012

As many as 74% of consumers would support a rapid, oral swab HIV test available over the counter, according to a survey released Friday by Who's Positive, a national HIV awareness organization.

April 5, 2012

OraSure Technologies on Wednesday announced that the Food and Drug Administration's Blood Products Advisory Committee will consider making its OraQuick Rapid HIV-1/2 test available over the counter on May 15.

February 23, 2012

The Food and Drug Administration has given tentative approval to a division of Mylan for a generic drug for treating HIV and AIDS in children in developing countries.

January 31, 2012

California state officials tentatively are blocked from moving forward with a 10% Medi-Cal reimbursement rate cut.

December 20, 2011

The World Health Organization has approved three generic second-line treatments for HIV made by Mylan, the drug maker said Tuesday. The drugs will be delivered to people in developing countries living with HIV and AIDS.

December 16, 2011

According to an article in the November/December issue of the journal Medical-Surgical Nursing, rates of HIV/AIDS, herpes, syphilis, human papilloma virus and other STDs are climbing steadily across men and women older than 50 years.

December 9, 2011

The Centers for Disease Control and Prevention on Thursday released new recommendations to treat latent tuberculosis infection.

November 10, 2011

Walgreens now has certified more than 500 of its pharmacies as HIV Centers of Excellence in communities highly impacted by HIV, as identified by the Centers for Disease Control and Prevention, the pharmacy operator announced Thursday at the U.S. Conference on AIDS.

November 7, 2011

The Magic Johnson Foundation on Monday initiated Point Forward Day, marking 20 years to the date that Johnson announced his HIV status and subsequent retirement from the National Basketball Association.

September 20, 2011

Mylan subsidiary Matrix Labs has received tentative approval from the Food and Drug Administration for its new drug application of a co-packaged antiretroviral treatment under the President's Emergency Plan for AIDS Relief.

August 16, 2011

The Community Education Group and the Urban Coalition for HIV/AIDS Prevention Services will sponsor a series of community mobilizing events around the country in the time leading up to the International AIDS Conference in Washington next July.

August 8, 2011

Specialty pharmacy services company Armada Health Care has enlisted a New York pharmacy professor to assist in the review of developed clinical protocols and medication assessment tools, Armada said Monday.

July 28, 2011

Skin care company Kiehl's Since 1851 is maintaining its long-standing tradition of supporting HIV/AIDS charities through a continued partnership with amfAR, the Foundation for AIDS Research. The initiative also involves the launch of a limited-edition ultra facial cream.

July 18, 2011

A statin made by Eli Lilly and Kowa Pharmaceuticals America appears to work well with drugs used to treat HIV, according to a study presented at the sixth International AIDS Society conference on HIV Pathogenesis, Treatment and Prevention in Rome.

July 13, 2011

Taking drugs for treating HIV might reduce the risk of infection among heterosexual couples, according to two new studies conducted in Africa.

June 22, 2011

Walgreens has teamed with Greater Than AIDS, a national campaign in response to HIV/AIDS in the United States, to distribute informational resources and specialized HIV-related services at more than 300 Walgreens pharmacies in heavily affected communities, the Kaiser Family Foundation announced Tuesday.

May 24, 2011

Several states are cutting funding to programs that provide HIV medications to people who can’t afford them in an effort to reduce spending, according to a published report.

May 12, 2011

Patients with HIV who immediately started antiretroviral therapy significantly reduced the risk of spreading the virus to an uninfected partner, compared with those who delayed therapy, according to results of a multinational study. The study also found that antiretroviral therapy reduced the risk of transmission by 96%.

May 9, 2011

Napo Pharmaceuticals has filed a lawsuit against Salix Pharmaceuticals, alleging that the latter breached commitments under an agreement to develop and commercialize a proprietary gastrointestinal compound.

March 10, 2011

A subsidiary of Mylan has won approval to sell a generic drug for HIV and AIDS in developing countries under the President’s Emergency Plan for AIDS Relief.

January 20, 2011

A nonprofit clinic that caters to New York’s gay, lesbian, bisexual and transgender communities and people living with HIV and AIDS has opened a new pharmacy.

January 20, 2011

The Food and Drug Administration has given tentative approval to an antiretroviral treatment for children with HIV and AIDS under the President’s Emergency Plan for AIDS Relief program.

December 21, 2010

Bristol-Myers Squibb has signed a definitive licensing pact with Oncolys BioPharma, a privately held Japanese biotech company, that will give it control of a promising new HIV treatment.

December 7, 2010

The Food and Drug Administration has given tentative approval to a generic drug for HIV/AIDS made by Mylan subsidiary Matrix Labs for distribution in developing countries under the President’s Emergency Plan for AIDS Relief, Mylan said Tuesday.